Multiple Sclerosis Drug Shows Promise for Enhancing Working Memory

Overview

• Fampridine, a drug used to aid walking in multiple sclerosis patients, may enhance working memory in those with cognitive impairments.
• The study found significant improvements in individuals with poor baseline working memory after three days of fampridine treatment.
• Researchers observed increased brain excitability, suggesting faster and more efficient neural communication.
• The potential for fampridine to treat cognitive deficits in conditions like schizophrenia and depression is being further explored.
• The study was a randomized, double-blind trial involving 43 healthy adults and highlights the need for personalized cognitive therapies.